Home Meetings Online CME/CE Clinical Resources EHR/EMR

East Annual Conference

Location: Boston, MA
Date: September 11-14, 2014

Meeting Overview

Venue:
Boston Convention & Exhibition Center
Primary Audience:
Primary Care
Credits:
Please refer to the CME Information Tab
Untitled Document

Thank you to all who joined us at Pri-Med East 2014. We look forward to seeing you next year!

For those who look to you—you can look to us.

Primary care is where good health begins. It is based on your relationship with your patients as you provide and coordinate the care they need, from preventive health to specialty care to inpatient services. The demands and challenges you face every day within your practice are constantly changing, so we’re changing with them.

We’ve taken the feedback of clinicians in your region and across the country to launch an all-new Annual Conference.

 

Download the conference brochure »

 

Already registered? Download the onsite guide to prepare for the conference »

 

Pri-Med Show

Earn up to 25.5 AMA PRA Category 1 Credits™, 25.5 AAFP Prescribed
credits, or 25.5 AANP contact hours of continuing education.

Quality CME

Pri‑Med has expanded its partnership with the American College of Physicians (ACP), and in collaboration with the ACP we are unveiling an entirely new cutting-edge CME curriculum.

The CME sessions will include the latest treatments and therapies, such as:

  • Live Demonstration Orthopedic Exam:
    See It, Do It
  • Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
  • In Search of Joy in Practice
  • State-Mandated Session: About My Error

Renowned keynote speakers include Dr. Michael Dansinger, a weight loss and nutrition consultant for NBC’s The Biggest Loser.

American College of Physicians

Session Schedule

 

Value for Your Time

In addition to over 30 new educational sessions, there are many new components of the conference that were created with you in mind.

  • The opportunity to taking advantage of preferred pricing on a Fitbit activity tracker and participating in the Steps to Success community—check out the Good Health tab for more details.
  • Ticketed events including, Unshackle Me: The Power of Google Glass to Liberate, with a live demo and panel discussion from leaders pioneering Google Glass in the clinical setting.
  • SAFE Opioid Prescribing certification sessions featuring a faculty meet and greet and book signing
  • A chance to participate in hands-on ultrasound workshops developed with the University of South Carolina School of Medicine Ultrasound Institute.

University of South Carolina School of Medicine

Keynote Speakers

CME Activities

Primary Care Updates* | September 11, 2014
Earn up to 6.5 AMA PRA Category 1 Credits™, 6.5 AAFP Prescribed credits, or 6.5 AANP contact hours of continuing education at these pre-conference sessions.

Annual Conference | September 12–14, 2014
Earn up to 19 AMA PRA Category 1 Credits™, 19 AAFP Prescribed credits, or 19 AANP contact hours of continuing education during the core curriculum.


Educational Symposia
Accredited CME sessions to expand your learning during breaks from the core curriculum. asdf

Learn More

 

Industry-Sponsored Opportunities

Exhibit Hall
Have face-to-face conversations with industry professionals, gain helpful takeaways, and experience engaging floor activities such as live demonstrations, outside your office hours.

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.

Presentation Theaters are not offered for CME credit nor is the content planned or reviewed by pmiCME, ACP, or UofSC.

Learn More

Pri-Med Mobile App Available Now

*Primary Care Updates tracks are sponsored by pmiCME and are produced independently of and are not affiliated with the ACP or UofSC. This is a limited-capacity ticketed event available during registration.

Sessions & Syllabus

For your convenience, we have printer-friendly syllabus slides available for you to download.

Print Primary Care Updates Syllabus

CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to Improve Patient Outcomes
Room: Grand Ballroom, Level 3
Learning Objectives:
  1. Describe the neurophysiologic mechanisms of circadian rhythms and adverse multisystem consequences of misalignment for patient health and function.
  2. Evaluate sleep patterns and symptoms of shift work disorder using clinical tools and strategies, such as sleep logs and the Epworth Sleepiness Scale.
  3. Diagnose shift work disorder based on identified symptoms, patient history and work schedule, and a comprehensive sleep history.
  4. Tailor therapeutic regimens for shift work disorder that include appropriate combinations of nonpharmacologic and pharmacologic modalities.
  5. Educate patients on the potential consequences of poorly managed shift work disorder and the fundamentals of sleep hygiene.
Faculty:
  1. Charles Czeisler, MD, PhD, Baldino Professor of Sleep Medicine, Harvard Medical SchoolBoston, MA, Senior Physician, Division of Sleep Medicine, Department of Medicine, Brigham and Women's HospitalBoston, MA
  2. Karl Doghramji, MD, Professor of Psychiatry, Neurology, and Medicine, Medical Director, Jefferson Sleep Disorders Center, Program Director, Fellowship in Sleep Medicine, Thomas Jefferson UniversityPhiladelphia, PA (Bio)
  3. Paul Doghramji, FAAFP , MD, Family Physician, Collegeville Family PracticeCollegeville, PA, Medical Director of Health Services, Ursinus CollegeCollegeville, PA (Bio)
CLOSE  X  
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
Room: Room 210, Level 2
Learning Objectives:
  1. Summarize fundamental similarities and differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet drugs.
  2. Explain efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials.
  3. Recognize guideline-based therapies to reduce risk and goals to achieve in the management of patients who have experienced an acute coronary syndrome.
Faculty:
  1. Jessica Mega, MD , MPH, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA
  2. Benjamin Scirica, MPH, MD, Assistant Professor of Medicine, Harvard Medical SchoolBoston, MA, TIMI Study Group, Cardiovascular Division, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
Applying Stroke and Bleeding Risk Assessment in Atrial Fibrillation to Optimize Anticoagulation Therapy
Room: Grand Ballroom, Level 3
Learning Objectives:
  1. Apply risk stratification strategies to identify stroke and bleeding risk in patients with AF.
  2. Review the coagulation cascade including the role of factor Xa and thrombin in the development of thromboembolic events.
  3. Summarize current evidence with available and emerging anticoagulants for stroke prevention in patients with AF.
  4. Implement guideline recommended therapy for AF stroke prevention taking into account individual patient stroke and bleeding risk.
  5. Apply strategies to improve patient medication adherence and safe switching of anticoagulant therapies.
Faculty:
  1. Bruce Stambler, MD, Director of Cardiac Arrhythmia Research and Education, Piedmont Heart InstituteAtlanta, GA
CLOSE  X  
Gout: Optimizing Disease Management 2014
Room: Room 210, Level 2
Learning Objectives:
  1. Recognize 2012 ACR guidelines for treating and managing acute and refractory gout.
  2. Integrate into their current practice paradigms current recommendations for lowering urate levels, treating inflammation, and preventing joint destruction.
  3. Develop counseling, education, and practice management strategies that promote better patient adherence to long-term therapies for gout.
  4. Implement current recommendations to prevent and treat gout flares.
Faculty:
  1. Michael Pillinger, MD, Associate Professor of Medicine, New York University School of MedicineNew York, NY, Section Chief, Rheumatology, New York Harbor VA Health Care System
  2. Mark Fisher, MD , MPH, Instructor, Harvard Medical SchoolBoston, MA, Assistant Physician, Massachusetts General HospitalBoston, MA
CLOSE  X  
Improving Outcomes in Type 2 Diabetes: Integrating GLP-1 Receptor Agonists Into Multimodal Treatment Regimens
Room: Grand Ballroom, Level 3
Learning Objectives:
  1. Discuss the pathologic mechanisms of T2DM that support the need for prompt diagnosis and aggressive treatment.
  2. Identify patient-centered treatment goals for patients with T2DM that encompass good overall glycemic control and improvements in other clinical parameters.
  3. Evaluate the clinical profiles of GLP-1 receptor agonists for the treatment of T2DM.
  4. Individualize therapeutic regimens for T2DM to maximize efficacy and minimize hypoglycemia, weight gain, and other potential treatment-related risks.
  5. Communicate with patients with T2DM about lifestyle modifications, antihyperglycemic options, and the need for treatment adherence.
Faculty:
  1. Vivian Fonseca, MD, Professor of Medicine and Pharmacology, Tullis Tulane Alumni Chair in Diabetes, Chief, Section of Endocrinology, Tulane University Health Sciences CenterNew Orleans, LA (Bio)
  2. Lawrence Blonde, MD, FACP, FACE, Director, Ochsner Diabetes Clinical Resarch Unit, Department of Endocrinology, Diabetes, and Metabolic Diseases, Ochsner Medical CenterNew Orleans, LA (Bio)
  3. Mark Stolar, MD, Associate Professor, Northwestern University Feinberg School of MedicineChicago, IL, Attending Physician, Northwestern Memorial HospitalChicago, IL
CLOSE  X  
The Evaluation and Treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in the Primary Care Setting
Room: Room 210, Level 2
Learning Objectives:
  1. Describe the pathophysiology and common comorbidities of BPH/LUTS.
  2. Implement comprehensive assessment of patients with BPH/LUTS.
  3. Select treatment options available to effectively treat BPH/LUTS.
Faculty:
  1. Martin Miner, MD, Chief of Primary Care and Community Medicine, The Miriam HospitalProvidence, RI, Co-Director, Men's Health Center, Clinical Associate Professor of Family Medicine and Urology, Warren Alpert Medical School, Brown UniversityProvidence, RI (Bio)
  2. Matt T Rosenberg, MD, Director and Founder, Mid-Michigan Health CentersJackson, MI, Chief, Department of Family Medicine, Foote Health SystemJackson, MI
CLOSE  X  
Lunch Break
CLOSE  X  
Lunch Break
CLOSE  X  
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
Room: Room 210, Level 2
Learning Objectives:
  1. Summarize the clinical evidence supporting the use of basal insulin therapy, with and without GLP-1 receptor agonists, in the management of type 2 diabetes.
  2. Incorporate strategies to overcome barriers to insulin use in the treatment of type 2 diabetes.
Faculty:
  1. Frank Lavernia, MD, Founder, North Broward Diabetes CenterDeerfield Beach, FL (Bio)
  2. Paul Jellinger, MD, Professor of Clinical Medicine, University of Miami Coral Gables, FL, Past President, Past President, American College of Endocrinology (ACE), American Association of Clinical EndocrinologistsJacksonville, FL, The Center for Diabetes & Endocrine CareHollywood, FL
  3. Richard Pratley, MD, Adjunct Professor, Sanford Burnham Medical Research InstituteOrlando, FL, Senior Scientist, Florida Hospital Sanford Burnham Translational Research InstituteOrlando, FL (Bio)
CLOSE  X  
Caring for Patients With Chronic Pain: Responsible Opioid Prescribing to Achieve Individualized Functional Goals
Room: Grand Ballroom, Level 3
Learning Objectives:
  1. Discuss the neurobiologic mechanisms that underlie chronic pain and associated functional disability.
  2. Assess biopsychosocial factors that contribute to chronic pain via patient histories, clinical interviews, and physical exams.
  3. Tailor multimodal opioid-based therapy for patients with chronic pain based on analgesia, functional responses, adverse events, and stratified risk of aberrant behaviors.
  4. Employ opioid prescribing principles for patient monitoring and documentation to comply with medical standards of care, government agencies, and risk evaluation and mitigation strategies.
  5. Educate patients about the safe and appropriate use of prescription opioid analgesics, including common side effects, drug-drug interactions, and the critical need to adhere to the therapeutic plan.
Faculty:
  1. Michael Brennan, MD, FACP, FASAM, The Pain Center of FairfieldFairfield, CT, Senior Attending Physician, Department of Medicine, Bridgeport HospitalBridgeport, CT (Bio)
  2. Bill McCarberg, MD, Adjunct Assistant Clinical Professor, University of California, San Diego School of MedicineSan Diego, CA, Founder, Chronic Pain Management Program, Kaiser Permanente San DiegoSan Diego, CA, Family Practitioner, Neighborhood HealthSan Diego, CA (Bio)
  3. David Simpson, MD, Professor of Neurology, Mount Sinai School of MedicineNew York, NY, Director, Clinical Neurophysiology Laboratories, Director, Neuromuscular Division, Director, Neuro-AIDS Program, Mount Sinai HospitalNew York, NY
CLOSE  X  
PM Break
CLOSE  X  
PM Break
CLOSE  X  
Current Perspectives and Emerging Approaches in Lipid Management
Room: Grand Ballroom, Level 3
Learning Objectives:
  1. Evaluate primary and secondary prevention evidence with statins.
  2. Explain the importance of lowering LDL-C for reducing cardiovascular risk, interpret statin safety data, and assess benefit/risk with statins.
  3. Explain the association of hypertriglyceridemia with increased risks and identify currently available therapies for reducing elevated triglycerides.
  4. Discuss similarities and differences between currently available and emerging omega-3 fatty acid agents, and indicate patient populations for potential incorporation of omega-3 fatty acids in clinical practice.
Faculty:
  1. Eliot Brinton, MD, FAHA , FNLA, Associate Professor of Medicine, University of Utah School of MedicineSalt Lake City, UT (Bio)
  2. JoAnne Foody, MD, FACC, FAHA, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
Current Approaches to Infectious Diseases in Primary Care
Room: Room 210, Level 2
Learning Objectives:
  1. Effectively assess and diagnose patients with common community-acquired infections
  2. Apply the latest guideline recommendations for appropriate treatment of pharyngitis, urinary tract infection, and cellulitis
Faculty:
  1. Kalpana Gupta, MD, MPH, Associate Professor of Medicine, Boston University School of MedicineBoston, MA (Bio)
Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Teva CNS, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo, Inc., AstraZeneca and Teva CNS and Endo Pharmaceuticals.
Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: AstraZeneca, Takeda Pharmaceuticals International, Inc., U.S. Region, Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com and Novo Nordisk Inc.
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
  
  
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:45 AM-9:00 AM
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to Improve Patient Outcomes
7:45 AM-9:15 AM
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
  
  
  
  
9:00 AM-9:15 AM - AM Break
 
9:15 AM-10:30 AM
Applying Stroke and Bleeding Risk Assessment in Atrial Fibrillation to Optimize Anticoagulation Therapy
9:15 AM-9:30 AM - AM Break
 
9:30 AM-10:30 AM
Gout: Optimizing Disease Management 2014
  
  
  
10:30 AM-11:45 AM
Improving Outcomes in Type 2 Diabetes: Integrating GLP-1 Receptor Agonists Into Multimodal Treatment Regimens
10:30 AM-11:45 AM
The Evaluation and Treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in the Primary Care Setting
  
  
  
  
11:45 AM-12:30 PM - Lunch Break
11:45 AM-12:30 PM - Lunch Break
  
  
12:30 PM-1:45 PM
Caring for Patients With Chronic Pain: Responsible Opioid Prescribing to Achieve Individualized Functional Goals
12:30 PM-2:00 PM
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
  
  
  
  
1:45 PM-2:00 PM - PM Break
 
2:00 PM-3:30 PM
Current Perspectives and Emerging Approaches in Lipid Management
2:00 PM-2:15 PM - PM Break
 
2:15 PM-3:30 PM
Current Approaches to Infectious Diseases in Primary Care
  
  
  
  
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
The Future of Medicine
Room: Hall B, Ground Level
Comprehensive overview of what is in the lab today and what is coming to market in the next 2 to 10 years. The presentation will concentrate on breakthrough developments ranging from 3D printing to organ regeneration, from point-of-care lab-on-a-chip diagnostics to large-scale bioinformatics; from synthetic biology to new gene based therapies. All of these and more are discussed in the context of current explosions of digital information and distributed healthcare.
Learning Objectives:
  1. Discuss future technologies that will impact healthcare and medicine.
  2. Understand key challenges of healthcare today and how emerging and exponential technologies can improve healthcare delivery and population health.
  3. Review some of the technologies that are helping to transform healthcare.
Faculty:
  1. Daniel Kraft, MD, Faculty Chair for Medicine & Neuroscience, Singularity UniversityPalo Alto, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Targeting Better Cardiac Outcomes for High-Risk Patients
This session will provide important update information on low HDL-C levels and elevated triglycerides as therapeutic targets to reduce cardiovascular disease risk.
Learning Objectives:
  1. Evaluate recent clinical trials with respect to management of low HDL.
  2. Examine the data on triglycerides and CVD risk to determine how aggressively to treat patients with elevated TGs.
  3. Employ strategies for reducing CVD risk in patients with type 2 diabetes and hypertension.
Faculty:
  1. Daniel Soffer, MD, Physician, Preventive Cardiovascular Medicine, Penn Medicine at Radnor, Perelman Center for Advanced Medicine, University of Pennsylvania Health SystemPhiladelphia, PA (Bio)
CLOSE  X  
Ultrasound for the PCP
Improve quality of care, patient safety, increased access to care, and practice autonomy through ultrasound. Learn about the advances in ultrasound technology, primary care applications, value-added to a primary care practice, and how best to learn ultrasound.
Learning Objectives:
  1. Identify the technology that has made ultrasound accessible to primary care providers.
  2. Identify three advantages of offering ultrasound in the primary care setting.
  3. Identify three clinical applications of point-of-care ultrasound in primary care.
Faculty:
  1. Richard Hoppmann, MD, FACP, The Dorothea H. Krebs Endowed Chair of Ultrasound Education, Professor of Medicine, Director of the Ultrasound Institute of the University of South Carolina School, University of South Carolina School of MedicineColumbia, SC (Bio)
CLOSE  X  
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
This session will provide new insight into the pathogenesis of dyslipidemia in the type 2 diabetic patient with chronic kidney disease and the rationale for advanced lipid testing (i.e., lipoprotein particle analysis) in those patients at high CV risk.
Learning Objectives:
  1. Describe the pathogenesis of dyslipidemias in patients with diabetes and chronic kidney disease.
  2. Understand the rationale for performing lipoprotein particle analysis in patients with high CV risk comorbidities.
Faculty:
  1. Matthew Sorrentino, FASH , MD, FACC, Professor of Medicine, Department of Medicine, Section of Cardiology, University of Chicago Pritzker School of MedicineChicago, IL (Bio)
CLOSE  X  
Introduction to Ultrasound and Case Presentations
Attendees will learn about point-of-care ultrasound applications, how ultrasound provides value to a primary care practice, advances in ultrasound technology, and how best to learn ultrasound. Ultrasound can improve quality of care, patient safety, increased access to care, and practice autonomy.This Ultrasound case-based presentation will focus on Heart Failure, Abdominal Pain, Musculoskeletal Pain, and Soft-tissue Infection
Learning Objectives:
  1. Understand the defining characteristics of point-of-care or the focused ultrasound examinations.
  2. Identify how point-of-care ultrasound can be used to diagnose and manage heart failure, abdominal pain, musculoskeletal pain, and soft-tissue infections.
Faculty:
  1. Richard Hoppmann, MD, FACP, The Dorothea H. Krebs Endowed Chair of Ultrasound Education, Professor of Medicine, Director of the Ultrasound Institute of the University of South Carolina School, University of South Carolina School of MedicineColumbia, SC (Bio)
  2. Victor Rao, MBBS, DMRD , RDMS, Director of Ultrasound Education, Radiology, Research Assistant Professor of Radiology, University of South Carolina School of MedicineColumbia, SC (Bio)
  3. Michael Wagner, MD, Primary Care Ultrasound Fellow, UofSC School of Medicine, University of South Carolina School of MedicineColumbia, SC (Bio)
  4. Keith Barron, MD, Chief Resident, UofSC School of Medicine, Primary Care Ultrasound Fellow at USC, University of South Carolina School of MedicineColumbia, SC
CLOSE  X  
Networking Break and Addtional Opportunities
CLOSE  X  
Ultrasound Workshops
Hands-on diagnostic workshops developed with The University of South Carolina School of Medicine Ultrasound Institute offered at an additional cost. Ultrasound Workshops will include six rotating modules on: Neck (thyroid, and ultrasound principles); Basic ECHO, Aorta, Inferior Vena Cava, Abdomen (gallbladder and liver); Knee (includes guided procedures)
Learning Objectives:
  1. Identify the essential features of portable ultrasound systems.
  2. Understand important practical principles of ultrasound image acquisition.
  3. Learn how to perform basic point-of-care ultrasound examinations of the neck, the heart, the abdomen, and the knee.
  4. Learn how to perform ultrasound guided procedures.
Faculty:
  1. Richard Hoppmann, MD, FACP, The Dorothea H. Krebs Endowed Chair of Ultrasound Education, Professor of Medicine, Director of the Ultrasound Institute of the University of South Carolina School, University of South Carolina School of MedicineColumbia, SC (Bio)
  2. Mary Elizabeth Poston, MD, FACP, Associate Professor of Clinical Internal Medicine, University of South Carolina School of MedicineColumbia, SC (Bio)
  3. Victor Rao, MBBS, DMRD , RDMS, Director of Ultrasound Education, Radiology, Research Assistant Professor of Radiology, University of South Carolina School of MedicineColumbia, SC (Bio)
  4. Michael Wagner, MD, Primary Care Ultrasound Fellow, UofSC School of Medicine, University of South Carolina School of MedicineColumbia, SC (Bio)
  5. Keith Barron, MD, Chief Resident, UofSC School of Medicine, Primary Care Ultrasound Fellow at USC, University of South Carolina School of MedicineColumbia, SC
  6. Paul Bornemann, MD, Assistant Professor of Family and Preventative Medicine, UofSC School of Medicine, Director of Primary Care Ultrasound, University of South Carolina School of MedicineColumbia, SC (Bio)
CLOSE  X  
Insulin Therapy in Patients with Type 2 Diabetes: Current and Emerging Basal Insulins
Learning Objectives:
  1. Outline the benefits of early insulin therapy in patients with type 2 diabetes.
  2. Discuss when insulin may be initiated for the treatment of patients with type 2 diabetes.
  3. Describe the advantages and disadvantages of various insulin regimens and apply them in clinical practice for the selection and titration of insulin in patients with type 2 diabetes.
  4. Identify the barriers to insulin-mediated glucose control and apply strategies to overcome them.
  5. Describe how improved pharmacokinetic and pharmacodynamic profiles of emerging insulins may reduce hypopglycemia and optimize insulin administration.
Faculty:
  1. Andrew Ahmann, MD, MS, Professor of Medicine, Director, Harold Schnitzer Diabetes Health Center, Oregon Health & Science UniversityPortland, OR
  2. Richard Beaser, Associate Clinical Professor of Medicine, Harvard Medical SchoolBoston, MA, Medical Executive Director, Professional Education, Joslin Diabetes CenterBoston, MA
CLOSE  X  
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
Practicing clinicians face the challenge of evaluating patients for aberrant drug behavior when prescribing opioid therapy for pain management. This session will help improve your ability to identify risk factors for drug-seeking behaviors and to differentiate between opioid tolerance, physical dependence and addiction. *This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
Learning Objectives:
  1. Identify risk factors for opioid-related aberrant behavior
  2. Differentiate between tolerance, physical dependence and addiction
Faculty:
  1. Charles Argoff, MD, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Assistant Professor of Neurology, New York University School of MedicineNew York, NY
**pmiCME designates the SAFE Opioid Prescribing Activity, for 0.5 credits of Pain Management. Please check your individual state licensing board requirements before claiming Pain Management credit.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
Improve your ability to adjust treatment when converting from immediate release opioid formulations to extended release/long-acting preparations, as well as your ability to identify risk factors for opioid-induced respiratory depression. *This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
Learning Objectives:
  1. Convert patients from immediate-release to ER/LA opioids as well as from one ER/LA opioid to another
  2. Identify predisposing risk factors for significant respiratory depression
Faculty:
  1. Jeffrey Gudin, MD, Director, Pain Management and Palliative Care, Englewood Hospital and Medical CenterEnglewood, NJ (Bio)
**pmiCME designates the SAFE Opioid Prescribing Activity, for 0.5 credits of Pain Management. Please check your individual state licensing board requirements before claiming Pain Management credit.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
Participatory medicine is being driven by e-health technology and represents a significant paradigm shift. Learn how e-messaging, patient health records/patient portals and online resources can improve and are improving patient care through improved communication between you and your patients.
Learning Objectives:
  1. Take advantage of online resources to expand your medical knowledge and augment your clinical expertise.
  2. Provide practical advice to patients about smart and appropriate use of web-based health information and social media.
Faculty:
  1. Daniel Sands, MD, MPH, Attending Physician, Beth Israel Deaconess Medical CenterBoston, MA, Assistant Clinical Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
Improve your ability to manage adverse reactions with extended release/long-acting opioid formulations and to monitor patient adherence to treatment. *This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
Learning Objectives:
  1. Evaluate and manage adverse effects of ER/LA-opioids
  2. Differentiate strategies for monitoring patient adherence
Faculty:
  1. Jeffrey Gudin, MD, Director, Pain Management and Palliative Care, Englewood Hospital and Medical CenterEnglewood, NJ (Bio)
** pmiCME designates the SAFE Opioid Prescribing Activity, for 0.5 credits of Pain Management. Please check your individual state licensing board requirements before claiming Pain Management credit.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Networking Break
CLOSE  X  
Networking Break
CLOSE  X  
Test Your Skills in Difficult Cases: Atrial Fibrillation
This session will provide important take away information on the use of anticoagulant therapy in afib patients that is evidence and guideline based. Also included will be approaches to differentiate between rate and rhythm control that can direct appropriate treatment strategies.
Learning Objectives:
  1. Describe current guidelines and clinical evidence regarding the use of anticoagulant therapy in patients with atrial fibrillation (AF).
  2. Differentiate between rate and rhythm control in AF and direct appropriate treatment strategies based on these parameters.
Faculty:
  1. Kent Nilsson, MD, FACC, Assistant Professor of Medicine, Director, Complex Ablations, Athens Regional Medical Center, University of Georgia/Georgia Regents UniversityAthens, GA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
This session will provide important take away strategies for counseling patients and caregivers to ensure appropriate use of extended release/long-acting opioids and recognition of signs of overdose. *This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
Learning Objectives:
  1. Implement counseling strategies to ensure patients know to take ER/LA opioids exactly as prescribed
  2. Use counseling strategies to explain signs of ER/LA opioid overdose to patients and caregivers
Faculty:
  1. Michael Brennan, MD, FACP, FASAM, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport HospitalBridgeport, CT, Assistant Clinical Attending Physician, St. Vincent's HospitalBridgeport, CT, Medical Director, MD, The Pain Center of FairfieldFairfield, CT (Bio)
** pmiCME designates the SAFE Opioid Prescribing Activity, for 0.5 credits of Pain Management. Please check your individual state licensing board requirements before claiming Pain Management credit.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
When individualizing your pain management treatment approach, learn how to assess differences in opioid metabolism and potential drug interactions in your patient, and how these factors will impact treatment. *This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
Learning Objectives:
  1. Assess the differences in opioid metabolism and how these impact appropriate ER/LA prescribing
  2. Identify how opioid-drug interactions influence ER/LA opioid prescribing
Faculty:
  1. Michael Brennan, MD, FACP, FASAM, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport HospitalBridgeport, CT, Assistant Clinical Attending Physician, St. Vincent's HospitalBridgeport, CT, Medical Director, MD, The Pain Center of FairfieldFairfield, CT (Bio)
** pmiCME designates the SAFE Opioid Prescribing Activity, for 0.5 credits of Pain Management. Please check your individual state licensing board requirements before claiming Pain Management credit.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
Elderly patients with dementia present the practicing physician with the challenge of managing the psychiatric and behavioral spectrum of this disorder: memory problems, mood disorders, sleep disturbances, apathy, delusions, hallucinations, wandering and agitation. This session will provide assistance in the differential diagnosis and the selection of appropriate pharmacologic and non-pharmacologic treatments for behavioral problems.
Learning Objectives:
  1. Differentiate the variation in symptoms of the dementing disorders depending upon their etiology.
  2. Apply appropriate pharmacologic therapies for behavioral problems associated with dementia.
  3. Apply appropriate non-pharmacological therapies for agitation with special attention to the environment.
Faculty:
  1. Katherine Galluzzi, FACOFP , DO, CMD, Professor and Chairperson, Department of Geriatric Medicine, Department of Geriatric MedicinePhiladelphia, PA, Medical Director, Hospice of Philadelphia, VNA of Greater PhiladelphiaPhiladelphia, PA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
Improve your understanding of the official prescribing information for available extended release/long-acting opioids, as well as the doses indicated for opioid-tolerant patients. *This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
Learning Objectives:
  1. Differentiate the prescribing information among available ER/LA opioids
  2. Identify ER/LA opioids and dosages indicated for opioid-tolerant patients only
Faculty:
  1. Charles Argoff, MD, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Assistant Professor of Neurology, New York University School of MedicineNew York, NY
**pmiCME designates the SAFE Opioid Prescribing Activity, for 0.5 credits of Pain Management. Please check your individual state licensing board requirements before claiming Pain Management credit.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Medical Knowledge Brain Game: SAFE Opioid Prescribing Edition
This session makes use of an engaging quiz show format to reinforce the essential elements in the appropriate use of opioids in pain management.
Faculty:
  1. Charles Argoff, MD, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Assistant Professor of Neurology, New York University School of MedicineNew York, NY
  2. Michael Brennan, MD, FACP, FASAM, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport HospitalBridgeport, CT, Assistant Clinical Attending Physician, St. Vincent's HospitalBridgeport, CT, Medical Director, MD, The Pain Center of FairfieldFairfield, CT (Bio)
  3. Jeffrey Gudin, MD, Director, Pain Management and Palliative Care, Englewood Hospital and Medical CenterEnglewood, NJ (Bio)
*This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA). ** pmiCME designates the SAFE Opioid Prescribing Activity, for 0.5 credits of Pain Management. Please check your individual state licensing board requirements before claiming Pain Management credit.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
 
 Ultrasound Sessions and Workshops | developed with the University of South Carolina School of Medicine Ultrasound Institute
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
The Future of Medicine
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Targeting Better Cardiac Outcomes for High-Risk Patients
9:45 AM-10:45 AM
Ultrasound for the PCP
 
 
 
10:45 AM-11:45 AM
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
10:45 AM-11:45 AM
Introduction to Ultrasound and Case Presentations
 
 
 
11:45 AM-1:45 PM - Networking Break and Addtional Opportunities
 
 
 
 
1:00 PM-5:00 PM
Ultrasound Workshops
 
 
1:45 PM-2:30 PM
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
1:45 PM-3:15 PM
*Insulin Therapy in Patients with Type 2 Diabetes: Current and Emerging Basal Insulins
 
 
2:30 PM-3:15 PM
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
 
 
3:15 PM-3:45 PM
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
3:15 PM-3:45 PM
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
 
3:45 PM-4:00 PM - Networking Break
3:45 PM-4:00 PM - Networking Break
4:00 PM-4:30 PM
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
4:00 PM-5:00 PM
Test Your Skills in Difficult Cases: Atrial Fibrillation
 
4:30 PM-5:00 PM
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
 
5:00 PM-5:30 PM
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
5:00 PM-6:00 PM
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
 
5:30 PM-6:00 PM
Medical Knowledge Brain Game: SAFE Opioid Prescribing Edition
 
*To date, Primary Care Updates has been supported by educational grants from the following organizations: Sanofi US Diabetes.
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Laughter is the Best Medicine
Room: Hall B, Ground Level
"Laughter is the Best Medicine" is the signature program of Brad Nieder, MD, CSP, a funny doctor, keynote speaker and clean comedian who blends healthcare humor with wellness advice and an uplifting message. Dr. Brad will explain how laughter really is good medicine ... for managing pain, enhancing immune system function, reducing stress and more. You'll be entertained and inspired to find more humor in your life and recapture the joy of medicine.
Learning Objectives:
  1. Understanding the health benefits of laughter such as: immune system enhancement, pain management, stress hormone reduction
  2. Implement workplace benefits of laughter such as: team unity, productivity, creativity
Faculty:
  1. Brad Nieder, MD (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
This session will provide guidance on whom to screen for obstructive sleep apnea in your primary care practice, how to screen, interventions and the differences you will encounter between male and female patients with this condition.
Learning Objectives:
  1. Implement practice-based procedures to screen and manage patients at risk for or with evidence of obstructive sleep apnea.
  2. Co-manage patients with OSA and encourage continued monitoring and compliance with CPAP therapy.
Faculty:
  1. Jonathan Lown, MD, Adjunct Faculty, Stony Brook UniversityStony Brook, NY (Bio)
CLOSE  X  
Infectious Diseases Update in Primary Care
This infectious disease update session provides guidance on applying current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis, differential diagnosis and management of latent tuberculosis infection, and evidence-based management of genital herpes.
Learning Objectives:
  1. Apply current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis.
  2. Differentiate the diagnosis of latent tuberculosis infection from that of active tuberculosis.
  3. Apply current evidence and guidelines to the clinical management of genital herpes.
Faculty:
  1. Kalpana Gupta, MD, MPH, Associate Professor of Medicine, Boston University School of MedicineBoston, MA (Bio)
CLOSE  X  
Fighting a Growing Epidemic: A Viral Hepatitis Update
This session will provide up-to-date guidelines for screening and evaluating patients with HCV virus infection in the primary care setting. Current best evidence will be presented to guide initiation of antiviral therapy and treatment monitoring for HCV and HBV.
Learning Objectives:
  1. Assess updated guidelines for screening and evaluating patients for HCV in the primary care setting.
  2. Direct antiviral therapy for HCV and HBV using best available evidence.
  3. Monitor patients for antiviral treatment response and toxicities.
Faculty:
  1. Nancy Reau, MD, Associate Professor of Medicine, Medicine, University of Chicago Chicago, IL (Bio)
CLOSE  X  
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis and pulmonary embolism. This session will assist you in identifying high risk medical and hospitalized patients in whom thromboprophylaxis should be initiated and appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Learning Objectives:
  1. Identify high risk medical and hospitalized patients for whom thromboprophylaxis should be initiated.
  2. Determine appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Faculty:
  1. Gregory Piazza, MD, Cardiovascular Division, Brigham and Women's Hospital, Instructor in Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Live Demonstration Orthopedic Exam: See It, Do it
Learn orthopedic maneuvers to assess common office-based musculoskeletal complaints.
Learning Objectives:
  1. Through live demonstration of orthopedic maneuvers, you will improve your ability to diagnose common musculoskeletal complaints of the upper body, low back, hip, and knee.
Faculty:
  1. Christopher Smith, MD, FACP, Associate Director, Internal Medicine Residency Program, Co-Director, Rabkin Fellowship in Medical Education, Beth Israel Deaconess Medical CenterBoston, MA, Associate Proessor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
Learning Objectives:
  1. Recognize the role of the renal system in glucose uptake, reabsorption, and the maintenance of glucose homeostasis and use the achieved knowledge to identify patients who would benefit from renally-targeted therapies.
  2. Explain the mechanism of action of sodium glucose linked transporter inhibitors and their role in modulating glucose homeostasis.
  3. Review professional guidelines from the ADA and AACE for target goals of therapy and treatment recommendations for specific patient-types.
  4. Identify the safety and efficacy profiles of current and emerging therapies that target renally-mediated glucose uptake and reabsorption.
  5. Implement management strategies that incorporate current and emerging therapies into treatment paradigms for patients who would benefit from a targeted approach to glycemic control.
Faculty:
  1. William Sullivan, MD, Senior Physician, Joslin Diabetes CenterBoston, MA, Assistant Clinical Professor of Medicine, Harvard Medical SchoolBoston, MA
CLOSE  X  
Medical Brain Game 2014: PCP Edition
Tough Questions Patients Bring to You
Learning Objectives:
  1. Compete in the popular yet practical medical knowledge game. New categories are sure to provide a fun challenge.
Faculty:
  1. M. Susan Burke, MD, FACP, Senior Advisor, Lankenau Medical Associates, Lankenau Medical CenterWynnewood, PA, Associate Professor of Medicine, Thomas Jefferson UniversityPhiladelphia, PA (Bio)
  2. Katherine Galluzzi, FACOFP , DO, CMD, Director, Comprehensive Care @ PCOM, Philadelphia College of Osteopathic MedicinePhiladelphia, PA, Professor and Chairperson, Department of Geriatric Medicine, Department of Geriatric MedicinePhiladelphia, PA, Medical Director, Hospice of Philadelphia, VNA of Greater PhiladelphiaPhiladelphia, PA (Bio)
CLOSE  X  
Networking Break
CLOSE  X  
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
This session will provide you with actionable information regarding insect pest borne infectious diseases, including the topic of the manifestations of Lyme disease and test interpretation to manage these patients and identifying body lice infestation with patient education regarding treatment and prevention.
Learning Objectives:
  1. Differentially diagnose common tick-borne diseases using symptomology, epidemiologic evidence, and lab tests, and prescribe antibiotic therapy as indicated.
  2. Diagnose and manage clinical manifestations of common pest infestations, including lice, mites, and bed bugs.
Faculty:
  1. Stephen Gluckman, MD, Professor of Medicine, Perelman School of Medicine, University of PennsylvaniaPhiladelphia, PA, Medical Director, Penn Global MedicinePhiladelphia, PA (Bio)
CLOSE  X  
Lipid Management: A Primary Care Perspective
Be up to date on current studies evaluating the benefits of raising HDL in reducing CV risk and how intense treatment should be to reduce residual risk for CHD.
Learning Objectives:
  1. Utilize evidence-based lipoprotein management strategies for non-LDL-C lipid targets.
  2. Describe the risk factors, disease spectrum, and appropriate management of familial hypercholesterolemia.
Faculty:
  1. Alan Brown, MD, FACC, FNLA, Director, Division of Cardiology, Advocate Lutheran General HospitalPark Ridge, IL, Clinical Associate Professor of Medicine, Stritch School of Medicine, Loyola UniversityChicago, IL, Medical Director, Midwest Heart Specialists at Advocate Healthcare, Midwest Heart Disease Prevention CenterChicago, IL (Bio)
CLOSE  X  
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
This session will provide actionable information for implementing current evidence-based guidelines to reduce CVD risk in type 2 diabetes patients and will utilize a case-based approach that addresses CV risk factors such a dyslipidemia and hypertension in these patients.
Learning Objectives:
  1. Identify key factors associated with increased cardiovascular outcomes in patients with type 2 diabetes
  2. Implement current evidence-based guidelines to reduce the risk of CV disease in patients with type 2 diabetes mellitus
Faculty:
  1. JoAnne Foody, MD, FACC, FAHA, Medical Director, Pollin Cardiovascular Wellness Program, Brigham and Women's HospitalBoston, MA, Staff Physician, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
Critical Caveats for Common Medications
Case-based review of side effects and drug interactions encountered with commonly used medications, including proton pump inhibitors, triptans, antibiotics, anticoagulants, NSAIDs and antidepressants.
Learning Objectives:
  1. Effectively manage patients who are on statin therapy with respect to potential drug interactions and muscle-related symptoms.
  2. Consider potential adverse effects of proton pump inhibitors, such as impaired absorption of certain nutrients, when prescribing as long-term therapy.
Faculty:
  1. Douglas Paauw, MD, Professor of Medicine, Rothman Family Foundation, Endowed Chair in Patient-Centered Clinical Education, University of Washington School of MedicineSeattle, WA (Bio)
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Laughter is the Best Medicine
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
9:45 AM-10:45 AM
Infectious Diseases Update in Primary Care
 
 
 
10:45 AM-11:45 AM
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
10:45 AM-11:45 AM
Fighting a Growing Epidemic: A Viral Hepatitis Update
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-3:45 PM
Live Demonstration Orthopedic Exam: See It, Do it
1:45 PM-3:00 PM
*Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
 
 
 
 
3:00 PM-3:45 PM
Medical Brain Game 2014: PCP Edition
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-5:00 PM
Lipid Management: A Primary Care Perspective
4:00 PM-5:00 PM
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
 
 
 
5:00 PM-6:00 PM
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
5:00 PM-6:00 PM
Critical Caveats for Common Medications
 
 
 
*To date, Primary Care Updates has been supported by educational grants from the following organizations: AstraZeneca.
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
Room: Hall B, Ground Level
Getting your patients to lose weight is never easy. Learn in this keynote address from the weight loss and nutrition consultant to NBC's "The Biggest Loser" about effective lifestyle and behavioral approaches to achieve weight loss goals in your overweight and obese patients.
Learning Objectives:
  1. Employ proven, evidence-based lifestyle and behavioral modalities to help your obese patients lose weight and achieve health benefits.
Faculty:
  1. Michael Dansinger, MD, Director of the Diabetes Reversal Program, Tufts Medical CenterBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
In Search of Joy in Practice: Innovations in Patient Centered Care
Learning Objectives:
  1. Identify 3 innovations to improve quality and satisfaction of practice
  2. Integrate cost-effective innovations into your practice
Faculty:
  1. Christine Sinsky, MD, General Internist, Medical Associates Clinic and Health PlansDubuque, IA
  2. Thomas Sinsky, MD, General Internist, Medical Associates Clinic and Health PlansDubuque, IA
CLOSE  X  
Women's Health Update: Clinical Pearls for Primary Care
Learning Objectives:
  1. Weigh the evidence for benefits versus harms when considering hormone replacement therapy for women with menopausal symptoms
  2. Proactively screen and treat elderly women to prevent falls and fractures
Faculty:
  1. Kelly Spratt, DO, FACC, FACP, Clinical Associate Professor of Medicine, University of PennsylvaniaPhiladelphia, PA (Bio)
CLOSE  X  
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
Improve your recognition of the signs and symptoms of major depressive disorder with differentiation from bipolar disorder. Improve your knowledge in the best practice selection of pharmacologic treatments for patients with uncomplicated depression and somatization.
Learning Objectives:
  1. Recognize the signs and symptoms of major depressive disorder (MDD) and initiate therapy with close monitoring.
  2. Differentiate bipolar disease from symptoms of depression in order to determine appropriate treatment.
  3. Consider actions and side effects of drugs and drug classes when deciding on which treatment to select for patients with psychiatric disorders.
Faculty:
  1. Rosalind Kaplan, FACP, MD, Director, Temple Health Women's Care, Temple University School of MedicinePhiladelphia, PA (Bio)
CLOSE  X  
Lung Sounds: A Primer on Pulmonary Auscultation
This primer on pulmonary auscultation will permit you to identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently, and link them to the scientific and literature validation that supports their clinical relevancy.
Learning Objectives:
  1. Recognize and identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently.
  2. Link literature validation and scientific basis to those sounds and extra-sounds which are clinically relevant.
  3. Establish a clinico-pathologic correlation for sounds and extra-sounds and murmurs.
Faculty:
  1. Salvatore Mangione, MD, Associate Professor of Medicine, Jefferson Medical CollegePhiladelphia, PA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Hot Off the Press and Into Your Practice 2014
You decide how your patient practice will be impacted after receiving updates on compelling new studies, clinical findings, and guidelines
Learning Objectives:
  1. Consider key findings from important new studies that can change your patient care.
Faculty:
  1. Marie Brown, MD, FACP, Governor, Illinois-N Chapter, American College of PhysiciansPhiladelphia, PA (Bio)
CLOSE  X  
Practical Approaches to the "Dizzy" Patient
Determine the etiology for symptoms that patients characterize as feeling dizzy or lightheaded, and the next appropriate course of action
Learning Objectives:
  1. Consider the potential etiologies for symptoms of lightheadedness or vertigo.
  2. Appropriately determine next steps, such as testing, referral or treatment based on clinical assessment.
Faculty:
  1. Aashish Didwania, MD, FACP, Associate Professor, Medicine, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
CLOSE  X  
Optimizing the Management of Patients with Chronic Kidney Disease
Address the challenges of patients with mild to moderate CKD with respect to slowing disease progression and treating blood chemistry abnormalities
Learning Objectives:
  1. Understand the impact of chronic kidney disease (CKD) as a common condition of the adult US population.
  2. Apply the latest evidence-based recommendations for diagnosis and management of patients with stages 1-3 CKD.
  3. Slow CKD progression by treating risk factors such as hypertension and diabetes.
Faculty:
  1. Ali Assefi, MD, Chief, Renal Section, Inova Fairfax HospitalFalls Church, VA, Assistant Clinical Professor of Medicine, Georgetown University Medical SchoolWashington, DC (Bio)
CLOSE  X  
About My Error
Learning Objectives:
  1. Detail how to prepare for error in the clinical setting, and how to handle an error when it occurs
  2. Outline how systems decrease the probability of error in order to affect practice-based changes that reduce clinical errors
  3. Create a culture of safety, rather than shame and blame, in your practice setting with respect to the management of clinical errors
Faculty:
  1. David Ring, MD, PhD, Associate Professor of Orthopaedic Surgery, Harvard Medical SchoolBoston, MA, Director of Research, MGH Orthopaedic Hand and Upper Extremity Service, Massachusetts General HospitalBoston, MA
* pmiCME designates the session; About My Error, for 1.0 credit of Patient Safety, Risk Reduction or Risk Management. Please check your individual state licensing board requirements before claiming Patient Safety, Risk Reduction or Risk Management credit.
 
 
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
In Search of Joy in Practice: Innovations in Patient Centered Care
9:45 AM-10:45 AM
Women's Health Update: Clinical Pearls for Primary Care
 
 
 
10:45 AM-11:45 AM
Lung Sounds: A Primer on Pulmonary Auscultation
10:45 AM-11:45 AM
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:45 PM
Practical Approaches to the "Dizzy" Patient
1:45 PM-2:45 PM
Hot Off the Press and Into Your Practice 2014
 
 
 
2:45 PM-3:45 PM
About My Error
2:45 PM-3:45 PM
Optimizing the Management of Patients with Chronic Kidney Disease
 
 
 

Ticketed Events

For 2014, Pri-Med is implementing a new ticketing policy to give all attendees equal opportunity to attend the additional events within the conference. Distribution of all additional opportunity tickets will happen at the Ticket Booth beginning at 6:45 each morning, as follows:

  • Friday, September 12: Ticket pick-up is available for Friday additional opportunities only. Limit 2 tickets per person.

  • Saturday, September 13: Ticket pick-up is available for Saturday and Sunday additional opportunities. Limit 4 tickets per person.

Please use this sheet to check off which additional opportunities you would like to attend and present it at the Ticket Booth after you have checked in.

AM Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Bipolar

Lunch 1

Non-CME Presentation Theater

11:50 AM-12:35 PM

Vaccines

11:50 AM-12:35 PM

Type 2 Diabetes

11:50 AM-12:35 PM

Depression

11:50 AM-12:35 PM

COPD

Lunch

CME Educational Symposia

12:00 PM-1:30 PM

Obesity

Lunch 2

Non-CME Presentation Theater

12:55 PM-1:40 PM

Statins

12:55 PM-1:40 PM

Crohn's Disease

12:55 PM-1:40 PM

Gastro

Dinner

CME Educational Symposia

6:15 PM-8:30 PM

COPD

AM Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Alzheimer's

8:55 AM-9:40 AM

Men's Health

8:55 AM-9:40 AM

Dupuytrens Contracture

Lunch 1

Non-CME Presentation Theater

11:50 AM-12:35 PM

Diabetes

11:50 AM-12:35 PM

Pancreatic Insufficiency

11:50 AM-12:35 PM

Overactive Bladder

12:00 PM-1:30 PM

Google Glass in Healthcare

Lunch 2

Non-CME Presentation Theater

12:55 PM-1:40 PM

Diabetes

12:55 PM-1:40 PM

Hepatitis C

12:55 PM-1:40 PM

Cardiac Imaging

AM Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Type 2 Diabetes

Lunch 1

Non-CME Presentation Theater

11:50 AM-12:35 PM

Obesity

11:50 AM-12:35 PM

Lipids

11:50 AM-12:35 PM

Atrial Fibrillation/Stroke

Lunch 2

Non-CME Presentation Theater

12:55 PM-1:40 PM

Asthma

12:55 PM-1:40 PM

Hypogonadism

CLOSE  X  
Bipolar Depression: Presentation, Diagnosis, and Treatment
Room: Theater 2
Faculty:
  1. J. Manning, MD, Adjunct Associate Professor, University of North Carolina at Chapel HillChapel Hill, NC (Bio)
CLOSE  X  
Pneumococcal Pneumonia and Invasive Disease in Adults: Help Protect Your Patients Aged 50+
Brought to you by: Pfizer Inc..
Room: Theater 2
Faculty:
  1. Yoav Golan, MD
CLOSE  X  
Improving Glycemic Control: A New SGLT2 Inhibitor for the Treatment of Adults with Type 2 Diabetes
Room: Theater 1
This program introduces a new therapeutic option in the newest class of oral antihyperglycemic drugs, the sodium glucose co-transporter 2 (SGLT2) inhibitors. The presentation will cover key information regarding the mechanism of action, phase III clinical development program, efficacy, safety profile, and dosing for this addition to the class.
CLOSE  X  
Discussion of a Treatment Option for Major Depressive Disorder
Brought to you by: Takeda Pharmaceuticals U.S.A., Inc..
Room: Theater 3
CLOSE  X  
GENETIC COPD: Rule out Alpha-1 in COPD Patients
Brought to you by: Grifols USA, Inc..
Room: Room 153
Faculty:
  1. Franck Rahaghi
CLOSE  X  
Engaging Your Patient in Obesity Management: Techniques, Tactics, and Tools for Customized Disease Treatment
Room: Room 210, Level 2
Learning Objectives:
  1. Describe diagnostic criteria and general goals of treatment for adult obesity.
  2. Determine appropriate multifaceted treatment approaches for adults with obesity, considering individual patient clinical characteristics, current treatment algorithm recommendations, and emerging evidence.
  3. Identify techniques, tactics, and tools to engage and support patients in the long-term management of obesity as a chronic disease.
Faculty:
  1. Donna Ryan, MD, Professor Emerita, Pennington Biomedical Research CenterBaton Rouge, LA (Bio)
  2. Scott Kahan, MD, Faculty, Johns Hopkins Bloomberg School of Public HealthBaltimore, MD, Director, National Center for Weight and WellnessWashington, DC, Clinical Director, STOP Obesity AllianceWashington, DC, MD
  3. Timothy Church, MD, MPH, PhD, Professor, Preventative Medicine Research Laboratory, Pennington Biomedical Research CenterBaton Rouge, LA (Bio)
The CME activity is supported by an educational grant from Novo Nordisk Inc..
CLOSE  X  
LIVALO: EMERGING CLINICAL CONSIDERATIONS AND KEY ATTRIBUTES
Brought to you by: Kowa Pharmaceuticals.
Room: Theater 1
Faculty:
  1. Daniel Wise, MD, FACC, FNLA
CLOSE  X  
PCPs and IBD: A Critical Connection
Brought to you by: AbbVie.
Room: Theater 2
Faculty:
  1. Peter Buch, MD, FACP, AGAF (Bio)
CLOSE  X  
Hepatic Encephalopathy: A Clinical Dialogue on a Chronic Complication of Cirrhosis
Brought to you by: Salix Pharmaceuticals, Inc..
Room: Theater 3
Faculty:
  1. Steven Flamm, MD
CLOSE  X  
Workshop: A Hands-On Approach to COPD Treatment
Room: Room 210, Level 2
Learning Objectives:
  1. Recognize the stages of COPD and identify the clinical features that differentiate COPD from asthma.
  2. Perform spirometry and interpret results to diagnose and classify disease severity in patients with COPD.
  3. Apply current guideline recommendations to individualize treatment with bronchodilators and anti-inflammatory therapies based on disease severity and classification for the long-term care of patients with COPD.
  4. Incorporate long-acting bronchodilators into COPD treatment regimens involving novel long-acting ß2-agonists and muscarinic antagonist therapies for the management of COPD.
  5. Demonstrate proper inhaler technique for various inhalation devices used to treat patients with COPD.
Faculty:
  1. Christopher Cooper, MD, Professor of Medicine and Physiology, David Geffen School of Medicine, University of California Los AngelesMarina del Rey, CA
  2. Emily Wan, MD, Instructor, Harvard Medical SchoolBoston, MA, Attending, Brigham and Women's HospitalBoston, MA
The CME activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc..
CLOSE  X  
Emerging Trends in Alzheimer’s Disease Management: Namenda® XR - a Treatment Option for Moderate to Severe Patients
Brought to you by: Forest Pharmaceuticals, Inc..
Room: Theater 1
Faculty:
  1. Robert Portney, MD
CLOSE  X  
Men’s Health Care Spotlight: The Management and Treatment of Erectile Dysfunction
Brought to you by: Auxilium Pharmaceuticals, Inc..
Room: Theater 3
Faculty:
  1. Andre Guay, MD, FACP , FACE
CLOSE  X  
Understanding Dupuytren’s Contracture: Disease Awareness for the General Practitioner
Brought to you by: Auxilium Pharmaceuticals, Inc..
Room: Theater 2
Faculty:
  1. Peter Stein D MD
CLOSE  X  
Improving Glycemic Control Through DPP-4 Inhibition: Treatment Considerations for Adult Patients With Type 2 Diabetes
Brought to you by: Boehringer Ingelheim & Eli Lilly.
Room: Theater 1
CLOSE  X  
Understanding the Data - Exocrine Pancreatic Insufficiency
Brought to you by: AbbVie.
Room: Theater 3
CLOSE  X  
Diagnosis and Management of Overactive Bladder
Brought to you by: Astellas Pharma U.S., Inc..
Room: Theater 2
Faculty:
  1. David Staskin, MD
CLOSE  X  
Unshackle Me: The Power of Google Glass to Liberate
Room: 205A
Brought to you by: VectorSpect Marketing, MedTech Boston and Medstro.com. Panelists include: Don Schwartz, Karandeep Singh, MD; Jennifer Joe, MD; Tristan Gorrindo, MD; Stephanie Shine, RN; and Carlos Rodarte.
CLOSE  X  
Advancing Paradigm Changes in Type 2 Diabetes Management
Brought to you by: Janssen Pharmaceuticals, Inc.
Room: Theater 1
Faculty:
  1. Stephen Brunton, MD, FAAFP
CLOSE  X  
Rethink HCV
Brought to you by: Gilead Sciences.
Room: Theater 3
Faculty:
  1. Thomas Sepe, MD
CLOSE  X  
Evaluating and Determining Patients for Cardiac Radionuclide Imaging
Brought to you by: Astellas Pharma U.S., Inc..
Room: Theater 2
Faculty:
  1. David Wolinsky, MD, FACC
CLOSE  X  
Supporting Nurse Practitioners and Physician Assistants in Diabetes Care: Targeting the Kidney in Type 2 Diabetes
Room: Theater 1
Faculty:
  1. Jane Kapustin, CRNP, PhD, University of Maryland School of NursingBaltimore, MD
CLOSE  X  
Addressing Chronic Weight Management With Targeted Pharmacotherapy
Brought to you by: Eisai, Inc..
Room: Theater 2
Faculty:
  1. Farhad Zangeneh, MD, FACP, FACE
CLOSE  X  
Understanding Triglycerides
Brought to you by: AstraZeneca.
Room: Theater 3
Faculty:
  1. James Underberg, MD, FASH , FNLA , FACPM , MS , FACP (Bio)
CLOSE  X  
Understanding Patient-Specific Factors in Stroke Prevention in Atrial Fibrillation (SPAF)
Room: Theater 1
Faculty:
  1. Christian Ruff, MD, MPH (Bio)
CLOSE  X  
Optimizing Inhaler Technique in Patients With Respiratory Diseases
Brought to you by: Teva Respiratory.
Room: Theater 1
Faculty:
  1. Stuart Stoloff, MD, FAAAAI, FAAFP
CLOSE  X  
Facts on Male Hypogonadism
Brought to you by: AbbVie.
Room: Theater 2

Accreditation

Earn up to 25.5 AMA PRA Category 1 Credits™, 25.5 AAFP Prescribed credits, or 25.5 AANP contact hours of continuing education.

Primary Care Updates – Tracks One & Two
September 11, 2014
Credits Type Accreditation Statement Designation Statement
6.5 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.5 AAFP This live activity, Primary Care Updates, with a begin date of 9/11/2014, has been reviewed and is acceptable for up to 6.5 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.5 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.5 contact hours of continuing education (which includes 3.250 hours of pharmacology).
Annual Conference
September 12—14, 2014
Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
19 AAFP This live activity, East Annual Conference, with a begin date of 9/12/2014, has been reviewed and is acceptable for up to 19 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
19 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 19 contact hours of continuing education (which includes 9.500 hours of pharmacology).

Keynote Speakers

Daniel Kraft, MD (Read Bio)

Singularity University, Palo Alto, CA

Presenting on:

Brad Nieder, MD (Read Bio)

Presenting on:

Michael Dansinger, MD (Read Bio)

Tufts Medical Center, Boston, MA

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Friday, September 12 8:30am–2:30pm
Saturday, September 13 8:30am–2:30pm
Sunday, September 14 8:30am–2pm

The Pri-Med Exhibit Hall is your chance to learn about and compare hundreds of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

 

Pri-Med Mobile App Now Available

Exhibit Floor Highlights

Presentation Theaters
Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Pri-Med Recharge Lounge
Relax. Recharge. Refuel. Visit this booth for complimentary coffee and small snacks during some of the break times.

Pri-Med Solutions Center
Stop by the Solutions Center to have any questions answered, update your contact information, find out about online resources and tools, and register for Pri-Med East 2015.

Amazing Charts
Visit the #1-rated EHR, Amazing Charts to start a FREE trial and get FREE Pri‑Med 2015 registration.

While you’re in session, we’ll get you started with a trial of Amazing Charts on your laptop** and give you a 1-on-1 demo when you return to pick it up.

**See minimum system specifications at amazingcharts.com/specs.

Exhibitor List

Company Name Booth Number
A Fashion Hayvin, Inc. 1508
AbbVie 2125
Alkermes Inc. 1632
Amazing Charts 1415
American Express Open 1809
American Occupational Therapy Association 2113
Argyll Diagnostics 1112
Astellas Pharma U.S., Inc. 1829
Auxilium Pharmaceuticals, Inc. 1713
Bankers Healthcare Group, Inc. 1222
BICOM, Inc. - Diaton 1134
Boehringer Ingelheim Pharmaceuticals, Inc. 1129
Calmoseptine, Inc. 1731
Cell Science Systems/ALCAT 2008
Cooley Dickinson Hospital 2313
CryoProbe 1010
Dannon Company 2109
Diva International Inc. 1715
Doctors Express 2423
Eisai, Inc. 1425
Enovative Technologies 1708
Exalenz Bioscience Ltd. 1832
Forest Pharmaceuticals, Inc. 1125
Genova Diagnostics, Inc. 1434
Gilead Sciences 1115
HAE: Learn About It, Talk About It 2316
Health Diagnostic Laboratory 1312
HireNurses.com 1628
ImpetoMedical 1520
Institute for Healthcare Improvement 2212
IPC The Hospitalist Company 1813
Kareo 2131
Lab USA, Inc. 2132
Lippincott Williams & Wilkins 1025
Magine Events 1908
Massachusetts Air National Guard 2314
Mederi Therapeutics, Inc 2216
MHM Services Inc. 1430
Millennium Health 1909
Mission Pharmacal Co. 1122
Monthly Prescribing Reference 1022
Needy Meds 2310
New England Journal of Medicine 1419
Novo Nordisk Inc. 1822
Nutramax Laboratories, Inc. 1012
Omron Healthcare 1016
Otto Trading, Inc. 1910
Pfizer Inc. 1929
Pri-Med InLight 1315
Pri-Med Recharge Lounge 1522
Rome Foundation 1613
Sanofi Pasteur Inc. 1915
Shire 1532
Southcoast Health 2115
Summit Doppler/Wallach Surgical Devices 1512
SureFit 1431
Takeda Pharmaceuticals U.S.A., Inc. 1625
Tec Laboratories, Inc. 1519
The Beef Checkoff 2112
The Gideons International 1610
Ultimate Creations 1709
US Army Healthcare 1423
Vital Nutrients 2130
Wearables NE 2422
Wexford Health Sources 1234
Xenna Corp. 1834
Company Name Booth Number
AbbVie 1925
Akrimax Pharmaceuticals LLC 1027
Alzheimer's Association 1009
American College of Physicians 1412
American Latex Allergy Association (ALAA) 1015
AndaMEDS 1223
AspirinWorks by Corgenix 1021
AstraZeneca 1218
Auxilium Pharmaceuticals, Inc. 1815
Bassett Healthcare 1023
Bionix Medical Technologies 2127
Boston Heart Diagnostics 1932
CEKeeper 1732
CleanSlate Centers, LLC 2210
Crown Healthcare Apparel Service 1934
CryoSurgery, Inc. 1030
Darco International 2213
Docnet 1024
Doximity 1418
Elsevier Medical Books 1019
Epocrates an athenaheath service 1331
Federal Bureau of Prisons 2215
GE Healthcare 2218
Gensco Laboratories 1028
Grifols USA, LLC. 1322
Harvard Vanguard Medical Associates 2315
Hemosure Inc. 1323
HydraFacial MD-Edge Systems LLC 1008
Infinite Therapeutics 1509
International Tree Nut Council Nutrition Research & Education Foundation 2108
Janssen Pharmaceuticals, Inc. 1108
Kowa Pharmaceuticals 1820
Laclede Inc. 1513
LocumTenens.com 1716
Maico Diagnostics 1031
Massachusetts Department of Public Health 1534
Merck 1618
Micro Direct 2116
Minute Clinic 1831
Mobisante Inc 2319
Mylan, Inc. 1729
Neilmed Pharmaceuticals, Inc. 1515
New York Times 1812
Nurse Practitioners OnCall, LLC 1634
OAPI-Medical Device Division 1615
Orasure Technologies, Inc. 2424
Owen Mumford, Inc. 1422
Pri-Med 1529
Pri-Med Knowledge Zone 1912
Renua Medical 2308
Sanofi 2118
Scarf King 1608
Singulex Inc. 1712
Steward Health Care System 1329
Sunovion Pharmaceuticals 1429
Take Shape for Life 1518
Takeda Pharmaceuticals U.S.A., Inc. 2121
TeleEMG 1032
The Boston Globe 2209
The Inline Group 1612
Upsher-Smith Laboratories, Inc. 1014
Verathon 2318
Vita-Mix Corp. 1808
Western Systems Research 2208
WynnPharm Inc. 1018
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Boston Convention & Exhibition Center
415 Summer St
Boston, MA 02210-1709
(617) 954-2000

Hotel Accommodations

Traveling from out of state? We’ve got you covered!
This year, we’re offering a 10% discount on Amtrak tickets to attendees that are traveling to Pri-Med East via the train. Boston South Station is conveniently located less than a mile from the BCEC.

Mention code: X93S-906 and receive 10% off your ticket price.
Amtrak Northeast Regional offers a 10% discount off the best available rail fare to Boston, MA between 9/7/2014–9/17/2014. To book your reservation call Amtrak at 1-800-872-7245 or contact your local travel agent. Discount reservations cannot be booked via Internet.

Good Health Begins Here

Untitled Document

As a practicing clinician, you are the focal point of all we do. This year’s Annual Conference theme, Good Health Begins Here, not only affords you the opportunity to take away key tips to improve the health and wellness of your patient population, but also encompasses many easy ways that you can improve your own health and wellness.

We believe good health begins with you, the clinician. You are setting the precedent and we’re here to help.

Keep checking back to see the new Good Health Begins Here features we’re adding to the event.

Pri-Med Show



CME: Keynotes

Three renowned keynote speakers including Dr. Michael Dansinger, a weight loss and nutrition consultant for NBC’s The Biggest Loser.

He will employ proven, evidence-based lifestyle and behavioral modalities to help your obese patients lose weight and achieve health benefits.

Dr. Daniel Kraft will present on “The Future of Medicine,” and Dr. Brad Nieder will present on “Laughter is the Best Medicine.”

 

Additional Offerings

Wellness Walk:

Taking place on both Saturday and Sunday morning to start your day off on the right foot.

• • • • • • • • • • • • • • • • •

Google Glass in Healthcare:

This ticketed event, Unshackle Me: The Power of Google Glass to Liberate, is being held on Saturday at noon. This session will include a live demo and panel discussion from leaders pioneering Google Glass in the clinical setting, including a wearable EMR that pushes relevant patient information to you, instead of you being tethered to your workstation. Imagine, no more COWs (big bulky computer on wheels)!

 

Exhibit Hall

Health and wellness book signings and meet‑the‑author opportunities including Dr. Walter Willett—author of Eat, Drink, and Be Healthy, Thinfluence and Eat, Drink, and Weigh Less on Friday, September 12 from 8:45–9:30am in
booth #331.

There will be 30 minute speaking engagement and the first 100 people that attended will receive a complimentary copy of his book: Eat, Drink and Be Healthy.

• • • • • • • • • • • • • • • • •

Access to the Nutrition and Wellness Pavilion on the Exhibit floor; exhibitors include:

  • The Dannon Company
  • International Tree Nut Council Nutrition Research & Education Foundation
  • The Beef Checkoff
  • Cell Science Systems/ALCAT

• • • • • • • • • • • • • • • • •

Knowledge Zones:

New this fall! Mini theaters designed for small collaboration work areas and intimate discussions on topics focused on health and wellness through the eyes of preventative care—diagnosing and treating to ensure your patients adhere to recommended treatments and therapies.

Knowledge Zone Schedule »

Steps to Success

Pri-Med is committed to helping improve your health and wellness, so we’re covering part of the cost of your activity tracker. Purchase yours and participate in the Steps to Success community. Prizes will be awarded throughout the walking challenge.

fitbit
You are eligible for one of the following products at a preferred rate:
  • Fitbit Zip: Your Price $30 | Retail Price: $59.95
  • Fitbit One: Your Price $59.50 | Retail Price: $99.95
  • Fitbit Flex: Your Price $59.50 | Retail Price: $99.95

A $150 AMEX gift card will be raffled off on the last Thursday of every month until May 2015 to a random participant. We’ll also be raffling off an additional gift card to a participant during the Annual Conference. Winners are selected at random and will be notified via the email in their Fitbit profile.

Take these steps to redeem your Fitbit at a preferred price:
  1. Register for Pri-Med East.
  2. During the Registration Process while building your itinerary, select the option for the Fitbit Challenge | Steps to Success.
  3. We’ll contact you with all the information you need to know!
Already have a Fitbit and want to participate? No problem! We want all our attendees to participate. During the registration process, simply select the option for “I have a Fitbit, but I want to join Steps to Success.”


Pri-Med Mobile App Available Now

Company
Exhibitors
Support
Terms
Tel: (877) 477-4633